PKC412
Showing 1 - 25 of 32
FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)
Available
- FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
- (no location specified)
Oct 18, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Boston (RAD001, PKC412)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- RAD001
- PKC412
-
Boston, Massachusetts
- +2 more
Mar 28, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Acute Myeloid Leukemia (AML) Trial in Germany, United States (cytarabine, daunorubicin HCl, midostaurin)
Completed
- Acute Myeloid Leukemia (AML)
- cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 16, 2020
Acute Myeloid Leukemia Trial in Germany (midostaurin (PKC412))
Completed
- Acute Myeloid Leukemia
- midostaurin (PKC412)
-
Chemnitz, Germany
- +9 more
Aug 5, 2020
Acute Myeloid Leukemia Trial in Worldwide (Midostaurin, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Midostaurin
- Placebo
-
Hong Kong, Hong Kong
- +40 more
Jan 20, 2023
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
FLT3-mutated Acute Myeloid Leukemia Trial in Hamilton, Montreal (Midostaurin)
No longer available
- FLT3-mutated Acute Myeloid Leukemia
-
Hamilton, Ontario, Canada
- +1 more
Oct 14, 2019
Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)
Terminated
- Acute Myeloid Leukemia (AML)
- Midostaurin
- +2 more
-
Chicago, Illinois
- +132 more
Jan 24, 2022
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point
Terminated
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +4 more
- Decitabine
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 17, 2019
Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in
No longer available
- Acute Myeloid Leukemia (AML) With
- FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
-
Phoenix, Arizona
- +43 more
Jul 14, 2020
Leukemia Trial in Houston (5-azacytidine, PKC412)
Completed
- Leukemia
- 5-azacytidine
- PKC412
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 18, 2018
Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in
Completed
- Systemic Mastocytosis, Aggressive (ASM)
- +2 more
-
Stanford, California
- +2 more
Sep 19, 2018
Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23
Terminated
- Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
- +7 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 25, 2018
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Acute Myeloid Leukemia Trial in Gainesville (Midostaurin, Cytarabine)
Withdrawn
- Acute Myeloid Leukemia
-
Gainesville, FloridaUniversity of Florida
Oct 18, 2018
Acute Myeloid Leukemia With Gene Mutations, Adult Acute Myeloid Leukemia in Remission Trial (Midostaurin)
Withdrawn
- Acute Myeloid Leukemia With Gene Mutations
- Adult Acute Myeloid Leukemia in Remission
- (no location specified)
May 1, 2018
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +5 more
-
Anchorage, Alaska
- +506 more
Jan 28, 2023
AML and High Risk MDS Trial in Worldwide (LGH447, LGH447 + midostaurin)
Completed
- AML and High Risk MDS
- LGH447
- LGH447 + midostaurin
-
Ann Arbor, Michigan
- +8 more
Dec 16, 2020